Optison Perflutren Protein-Type A Microspheres .22 mg/mL

Optison Perflutren Protein-Type A Microspheres .22 mg/mL is an injectable solution used for contrast enhancement in ultrasound imaging. This product, manufactured by GE Healthcare Inc., is designed to improve the visibility of blood flow and cardiac structures during diagnostic procedures.

Optison Perflutren Protein-Type A Microspheres .22 mg/mL is primarily used as a contrast agent in ultrasound imaging. It helps to enhance the visibility of blood flow and cardiac structures, making it easier for healthcare professionals to diagnose and monitor various conditions. This solution is administered intravenously and is commonly used in echocardiography to improve the clarity of images.

When administered, Optison Perflutren Protein-Type A Microspheres .22 mg/mL works by enhancing the reflection of ultrasound waves, which improves the quality of the images produced. This can lead to better visualization of blood flow and cardiac structures, aiding in more accurate diagnoses. The effects are typically temporary and related to the imaging procedure.

Optison Perflutren Protein-Type A Microspheres .22 mg/mL should be handled with care and administered by healthcare professionals. It is important to follow proper storage and handling guidelines to ensure the integrity of the solution. Patients should inform their healthcare provider about any allergies or medical conditions before administration.

Optison Perflutren Protein-Type A Microspheres .22 mg/mL may interact with certain medications or medical conditions. It is important to discuss any current medications or health issues with a healthcare provider before use. Additionally, interactions with other contrast agents or imaging procedures should be considered.